On cosmetics FDA certification

Cosmetics voluntary registration scheme ( VCRP )
FDA Office of cosmetics and colors should be cosmetic industry requirements developed cosmetics voluntary registration scheme. Program includes two parts: cosmetics manufacturers voluntarily registered and cosmetic ingredient statement.
To participate in the benefits of VCRP
The manufacturers voluntarily registered and the registration number is not indicated on the FDA manufacturer or its product approval, FDA does not allow manufacturers to use in VCRP or obtain the registration number or the column name for commercial publicity; but the manufacturers can directly obtain the following benefits through participation in VCRP:
Cosmetic composition important information acquisition. FDA from VCRP to get all the information into the computer database. If the current use of a cosmetic composition once considered to be harmful and should be disabled, FDA will use VCRP database in the mail list notice product manufacturers or distributors. If your product is not registered in the database, FDA will not be able to tell you.
Avoid components led to a product recall or import detained. If the cosmetics manufacturers product formula in VCRP record, as long as the FDA that manufacturers for use in formulations of the unapproved additives pigment or disable components, manufacturers pay attention to remind. So, manufacturers can be the product of import or sales before the modification product formulation, thus eliminating the because of improper component use led to a product recall or withholding of risk. Help retailers to identify safety conscious producers. Retailers ( such as a department store ) sometimes ask FDA for a cosmetics company is registered in FDA. Although registered does not mean that the FDA approved, but it shows you the products through the FDA review and entered the government database. If you submit the product formula is incomplete, or contains a disable components or unapproved additives pigment, FDA will notify you.
Sample acquisition decisions based on the nature of the product; FDA focus problem; product 's previous history. FDA made a physical sample and it will be sent to the laboratory for analysis of FDA area
If the FDA finds samples that meet the requirements, the United States Customs and importers were to send a" release notice".
If the FDA concluded," in violation of sample FDCA and other relevant legal performance", respectively to the United States Customs and case and importers send" seizure and notice of hearing". Notice details of illegal and nature and to the case and the importer of 10 working days to provide the goods may be permitted evidence.
Has seized imported goods must be in the FDA or the United States Customs under the supervision of dressing, returned or destroyed
Hearing is the importer for imported goods or provide evidence to defend the trimmed for the only entry opportunity.
If the case and the Underwriters, the owner, the importer or a designated representative don't notice of replies to the United States, FDA customs and importers to send" case and refused admission notice". Then the problem of product return or destruction.
If the case and the Underwriters, the owner, the importer or a designated representative responded to a" seizure and a notice of hearing", when the importers to provide evidence of product" to meet the requirements of" or submit dressing product applications, FDA has seized products hearings.
If the company provides products to meet the requirements of the evidence, FDA will collect the follow-up sample. The analysis after the decision, product or is the release or refused entry.
FDA audit importers proposed trimming procedures, depending on the circumstances, be approval or disapproval. Once approved, the FDA will conduct follow-up inspection / sampling to determine their eligibility. If the sample is qualified, the United States Customs and importers to import release notice is sent"". If samples are not qualified," refused admission notice".
FDCA eighth ( C ) section requires the applicant to pay all the cost of, in addition to update the label or other seizure of goods in line with the application ( form FDA-766) in terms of the relevant measure of the costs, including FDA officials or employees of travel, daily and wages. By submitting a FDA-766 form, the applicant agrees to pay all expenses according to the current regulations of supervision.